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INTRODUCTION 
With the continual increase in the number and types of chemical 
entities available for drug therapy, a corresponding increase in 
interest regarding the rrechanisms by which these agents are inac­
tivated has developed. This topic is a main concern of current 
literature. In selecting drug therapy for one of the present drug 
treatable diseases, a clinician will generally be able to select 
from more than one family or group of drugs. On occasion, it may 
be desirable to use more than one drug which may or may not be 
of the same chemical family or group. In any case, the importance 
1 
of locating the site of inactivation is increasin_g in stature. A 
question that might arise is whether or not the concurrent use of two 
or roore types of agents would compete for the sane site of i nacti­
vation. It would seem that before this could be determined, the 
location and the mechanism of inactivation for each group or family 
of drug agents involved should be determined. 
Recently interest has been directed towards other systems that 
might be affected in addition to those for \ihi ch the drug was admi n­
i s te red. Because the liver is the main detoxifying organ, emphasis 
has been placed on the alteration of microsomal enzyme activity in 
this tissue. Sorre of the early work in this area was performed by 
Conney et.!}_. (1 ) who evaluated rat liver enzyme induction caused by 
phenobarbital.· In this work these investigators found that injection 
of phenobarbital caused a several-fold increase in the microsomal 
enzyme activity of young rats. A considerable increase in activity 
was demonstrated within a 24-hour period following the administration 
of the drug. In addition to the increase in enzyne activity, the drug 
also caused an increase in the size of the livers. This effect is 
attributed to increased enzyme formation resulting in a higher protein 
content of  the treated livers. 
Orrenius et tl• (2) state that prolonged phenobarbital treat­
ment leads to an increase in both liver weight and microsomal protein 
per unit of liver weight . Both values returned to normal within two 
weeks following the discontinuance of phenobarbital. 
The studies o f  Arias et tl• (3) indicate that one-half of  the 
rat 1 iver protef ns turn over within 2. 5 days. The evidence obtained 
by the use of  electron microscopy indicates that synthesis .of  micro­
somal enzymes occurs primarily in smooth endoplasmic reticulum. 
The findings of  Holtzman and Gillette (4) led them to conclude 
· that s ti mul ati on o f  protein production was res pons i b 1 e for the in­
crease in endoplasmic reticulum components following phenobarbital 
administrati on .  These results supported earlier work of a similar 
nature by Conney and Gi 1 man ( 5) , and Orreni us et_ !}_. ( 6). It 
has become generally accepted that elevated levels of  microsomal 
enzyrre activity following phenobarbital administration is due to 
increased synthesis of protein and is not the result of  decreased 
protein breakdown . 
Many drug products are dealkylated by liver enzyrres. An example 
is the derrethylation of aminopyrine by mi crosomal demethylase. This 
enzyrre has becorre a valuable investigational tool for the measurement 
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of enzyrre activity alterations caused by drug administration . The 
removed methyl groups from aminopyrine can be converted to formal­
dehyde which can be readily assayed (7). 
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Eling et tl• (8) noted that the intraperitoneal administration of 
diphenylhydantoin causes an increase in the hepatic metabolism of 
hexobarbital, benzphetamine and aminopyrine in neonatal rats. Diphenyl­
hydantoi n increased 1 i ver weight but did not change the concentration of 
protein in the liver tissue. These investigators also demonstrated the 
metabolism of aminopyrine and benzphetamine in adult rats. A previous 
report of Platt and Cockrill (9) indicated sorrewhat different results. 
They did not observe a diphenylhydantoin-induced alteration in liver 
size nor increase in the metabolism of aminopyrine by microsomal enzyrres . 
A possible factor in these results may be that the rats of Platt and 
Cockrill were given diphenylhydantoin orally which possibly did not 
result in blood levels of the drug sufficiently high to initiate 
enzyme induction. 
Anti-epileptic agents are occasionally used concurrently to achieve 
better control of the disease {10) .  The effect that each agent has 
on microsomal enzyme activity could have considerable_bearing on the 
dosage and the frequency with which the drug is to be administered. 
The rretabol i c degradation of di phenylhydantoi n can be enhanced_ by the 
simultaneous administration of phenobar_bital and certain other drugs 
(1 1 ). Since both phenobarbital and diphenylhydantoin are occasionally 
used together in treatrrent of the epileptic, dosage adjustments must 
be made to achieve an optimal maintenance regimen .  This type of drug 
interaction might also suggest close scrutiny of medicaments that 
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might be administered for other purposes to patients on phenobarbital, 
diphenylhydantoin or any other agents. Phenobarbital is not the only 
agent that is known to alter the drug metabolism because of its influence 
on microsomal activity; the list is long and diverse including such 
chemicals as 3-methylcholanthrene, 3,4-benzpyrene and chlordane (8). 
The study of the effects of phenobarbital on liver microsomal 
enzyrre activity has been rather extensive (l-6,11) . As a result 
phenobarbital appears to be a "yards ti ck" by which many enzyme i nduc­
ti on studies are compared. Although some work has been done in this 
area using diphenylhydantoin, its study has not been nearly so exten­
sive. 
Of the many anti-epileptic agents available, the roost commonly 
used compounds can be divided into four categories: the barbiturates 
and related drugs, the hydantoins, the oxazolidines and the succin­
imides (12). Because of the possibility of concurrent use of the 
compounds in the treatrrent of epilepsy, it would be advantageous to 
have some information concerning the effect that each group has indi­
vidually on microsomal enzyme sys terns before therapy is instituted . 
This information would enable the clinician to more ad_equately predict 
drug response thus reducing dosage regimen adjusting time and also 
possibly reducing the incidence of adverse reactions or interactions. 
The effect of both phenobarbital and diphenylhydantoin on microsomal 
enzyrre activity has been previously explored and the objective of 
this study was to investigate what effects the administration of 
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trimethadione and ethosuximide would have under similar circumstances. 
Little or no information has been published.on the influence of the 
latter two compounds on derrethylase activity. 
For this study the barbiturates were represented by phenobarbital , 
the hydantoins by diphenylhydantoin, the oxazolidines by trimethadione, 
and the succinimides by ethosuximide. Following short term adminis­
tration of each agent, the microsomal demethylase activity of rat 
liver was determined. Dosages were approximately five times the 
reconmended normal human dai 1y dose for each of the agents (1 3) .  
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MATERIALS AND METHODS 
Adult, female Sprague-Dawley rats (3 roonths old, 159-225 grams) 
were used for this study. The animals were provided Purina Labo­
ratory Chow and water ad }j_bi tum. The temperature of the room housing 
the animals was maintained at 75-78 degrees fahrenheit. 
Co111>ounds under investigation were all corm-only used anti­
epileptic agents. They included sodium phenobarbital (sodium 5-
ethyl-5-phenylbarbi turate) ,  sodium di phenylhydantoi n (sodium 5 , 5-
diphenyl-2 , 4-imi dazol i di nedi one; Oilantin Sodiu�, Parke-Davis), 
·trimethadione (3,5, 5-triroothyl-2,4-oxazolidinedione; Tridione®, 
Abbott) and ethosuximi de (2-ethyl-2-nethylsucci nimi de; Zaronti n�\ 
Parke-Davis). Sodium phenobarbital was obtained from Merck and 
Corfl)any, Inc. of Rahway, New Jersey, and has the following chemical 
structure: 
Sodium Phenobarbital 
Triwethadione was obtained from Abbott Laboratories of North Chicago, 
Illinois, and· has the following chemical structure: 
Tri rre th adi one 
Sodium.diphenylhydantoin and ethosuximide were obtained from Parke, 
Davis and Company of Detroit, Michigan, and have the following chemical 
structures: 
Sodium Diphenylhydantoin Ethosuxi mi de 
The drugs were prepared fresh daily in 0.9 per cent saline. 
Dosages employed were 9 mg/kg of sodium phenobarbital , 30 mg/kg of 
sodium diphenylhydantoin, 90 mg/kg of trirrethadione and 54 mg/kg of 
ethosuximide. Dilutions of the drugs were prepared to allow 
administration of each compound at the rate of 3 ml/kg. All groups 
were given injections daily for five days prior to sacrifice. The 
dosages were calculated on the weight of the individual animals on 
the initial day of injection. 
The animals were housed in pairs for approximately one month 
prior to testing. One day before the injections were to begin, they 
were randomly divided into groups · of five animals, weighed and placed 
in individual cages. These cages were then placed in horizontal rows 
on the rack. 
Derrethylase-activity was.measured by the modified method of 
La Du et tl• (7). In this reaction aminopyrine is derrethylated by 
rat liver to yield two molecules of formaldehyde a·nd one molecule of 
7 
4-aminoantipyrine. The following reaction illustrates the manner 
in which this demethylation occurs: 
Ami nopyri ne Monorrethyl-4-




The addition of semicarbazide to the reaction mixture ties up the 
demethyl ated one carbon forr1al dehyde uni ts and thus prevents them 
from escaping. The formaldehyde is released by the addition of 
50 percent trichloroacetic acid solution. The quantity of formaldehyde 
can then be detennined. These investigators also established many 
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of the requirements for optimum demethylase activity. Each flask con­
tained 1 00 micromole·s of nicotinamide, 75 micromoles of magnesium chloride, 
0.2 micromoles of nicotinamide adenine dinucleotide phosphate (NADP), 5 
micromoles of aminopyrine, 2 micromoles of adenosine triphosphate, 3. 8 
micromoles of glucose-6-phosphate, 0.1 ml of 0. 1 molar semicarbazide and 
phosphate buffer (pH 7. 4) was added to bring the mixture to 5,ml. 
On the sixth· day following the initiation of the drugs, the 
rats were weighed and sacrificed by decapitation. A portion of the 
l iver was inmediatel y removed, weighed and pl aced_in a Potter El vehjem 
glass homogenizer. Sufficient phosphate buffer (pH 7.4) was added 
to yield a 10 percent concentration of tissue. After thorough 
homogenization, a 1.5 ml aliquot, representing 150 mg of liver tissue, 
was removed and placed in a 50 ml Erlenmeyer flask containing the 
incubation mixture. The flasks were then pl aced in a Dubnoff Metabolic 
Shaker and incubated at 37 degrees centigrade for one hour in open 
air. 
Previous work by Gross (14) showed that foll owing sixty minutes 
of incubation at 37 degrees centigrade, the reaction is complete. At 
the concl usion of the incubation period, the flasks were reMoved from 
the incubator, cooled in an ice bath and the reaction stopped by the 
addition of 5 ml. of 10 percent trichloroacetic acid solution. After 
swirl ing the flask to allow complete precipitation, the contents were 
centrifuged at 3700 X g for 10 minutes to cause separation of the 
protein material. Five ml of 50 percent trichl oroacetic acid solution 
was then added resulting in a trichloroacetic acid concentration of 
approximately 20 percent. The purpose of this step was to free the 
fonnaldehyde from the semicarbazide so the volatile substance coul d 
then be distill ed. 
The supernatant was then placed in a conventional distill ation 
apparatus and the first 5 ml of distillate was collected. From this 
5 ml aliquot, a l ml portion was used for the formaldehyde assay. 
9 
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Previous studies indicate that at least 99 percent of the formaldehyde 
present is distilled in the first 5 ml of distillate {1 4). 
The chronotropic acid {4,5-dihydroxy-2,7-naphthalenedisulfonic 
acid disodium salt) nethod of Mac Fayden {1 5) , irooified by Muel ler 
and Mi 11 er (1 6) and La Du et .!L• ( 7) was used to determine the amount 
of fonnaldehyde found. The amount of formaldehyde produced is directly 
proportional to the demethylation of aminopyrine; therefore, an 
accurate neasurerrent of derrethylase activity can be made. In this 
nethod a 1 ml aliquot of the distillate was added to a 4 ml portion 
_of freshly prepared chromotropic acid solution. The mixture was then 
p 1 aced in a boiling water bath for 30 minutes. Caution was taken to 
minimize steam escaping around the tubes subsrerged in the water bath 
becau·se of the hydroscopi c nature of 1 2  rrol ar sulfuric acid in the 
reagent. After a 30 minute deve lop�nt period, the tubes were removed, 
cooled, and the optical densities read in a Bausch and Lomb Spectronic 
20 at 570 nanometerse The presence of formal dehyde was indicated by 
the deve loprrent of a purple color. 
The remainder of the liver was excised from the rat, rinsed in 
phosphate buffer {pH 7. 4), pat dried and weighed. Thi_s weight plus 
the weight of the portion rerooved for the homogenate were combined to 
give the tota 1 rat 1 i ver weight. 
The volu1re of original 10 percent tissue homogenate was sufficient 
to perform a protei n determination. Thi_s determination was performed 
by the Bi uret nethod (17). A 1 ml aliquot of the homogenate was diluted 
to 10 ml with distilled water. A 2 ml portion of this dilution was added 
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to 8 ml of Biuret reagent. Upon standing at room temperature for 30 
minutes, the development of a blue color indicates the presence of 
protein in the solution. Because of a slight opacity due to undissolved 
material, all solutions were filtered prior to reading in a Bausch and 
Lonb Spectronic 20 at 550 nanorreters. The extent of color develop�nt 
in the Biuret test is a quantitative indicator of the amount of protein 
present. 
A standard curve for the Biuret test was established using four 
dilutions, O. 4, O. 6, 1 .  O, and 1 .  6 mi 1 1  i grams of protein. · Pepsin was 
the protein used in the analysis. Four individual runs of each con­
centration were averaged to arrive at the standard curve (Figure 1 ). 
The results were read photofll?tri cal ly at 550 nanometers. 
A standard curve for formaldehyde was made by using the following 
concentrations of formaldehyde: 0. 1 ,  0. 2, 0.3, 0. 4, and 0.5 microrroles 
per 5 ml. These di 1 uti ens were then run through the chromotropi c acid 
procedure and the data used to make the standard curve (Figure 2) . 
This curve is the result of five detenninations. The results were 
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Fig. 1. Standard Biuret curve. Optical density versus 
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Fig. 2. Standard formaldehyde curve. Optical density versus 
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RESULTS 
The influence of phenobarbital, diphenvlhydantoin, trimethadione 
and ethosuximide on �he derrethylase activity o-E 1-0�.!!.9. adult female 
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ratj_. To determine the effect of certain commonly used anti-epileptic 
agents on derrethylase activity, 9 mg/kg of phenobarbital, 30 mg/kg of 
diphenylhydantoin, 90 mg/kg of trimethadione and 54 mg/kg of ethosuxi­
mide were administered intraperitoneally to young adult female rats for 
five successive days. Control animals were given 3 ml/kg of 0. 9 percent 
saline under the same conditions. On the sixth day the animals were 
sacrificed, a portion of the 1 i ver tissue was removed and weighed, and 
the microsomal derrethylase activity was measured. The results of the 
experi rr.ent are shown on Tab le 1 , where each figure represents the 
average of enzyrre determinations on the livers of five animals. Unless 
otherwise stated, derrethylase activity is expressed as micromoles of 
formaldehyde produced by 150 mg of liver tissue in 60 minutes. The 
results of this study indicate that 9 mg/kg of phenobarbital and 
54 mg/kg of ethosuximide stimulate enzyme activity by 100. 2 percent 
and 37. 4 percent respectively, that 90 mg/kg of trirrethadione had little 
or no effect and that 30 mg/kg of diphenylhydantoin s11ghtly depressed 
derrethylase activity. 
The influence of phenoba rbi ta 1 , di pheny 1 hydan toi n, t ri meth adione 
_ and ethos·uximide on the concentratio_n_ of pro�ein i'l rat liver· tissue. 
To determine the effect of 9 mg/kg of phenobarbital, 30 mg/kg of 
diphenylhydantoin, 90 mg/kg of trimethadione and 54 mg/kg of ethosuxi­
mide on the protein concentration of rat liver tissue, 1 ml of the 
TABLE 1 
THE I NFLUENCE OF PHENOBARBITAL, DIPHENYLHYDANTOrn , TRIMETHADIONE 
AND ETHOSUXIMIDE ON THE DEMETHYLASE ACTIVITY OF  YOUNG ADULT 
FEMALE RATS 
GROUP ENZYME ACTIVITY* MI CROMOL ES HCHO PE RCENT 
1 5  




Tri rrethadi one 
Ethosuxi mi de 
per 1 50 mg tissue LIVE R TI SSUE* 
per 60 minutes) 
0 . 059 0 . 393  
( 0 . 045 -0 . 072 }  
0 . 1 1 8  0 . 787 +1 00 . 2  
( 0 . 085-0 . 1 75 )  
0 . 049 0 . 327  - 1 6  . 8  
( 0 . 047-0 $ 05 3 )  
0 . 060 0 . 400 + 1 . 8 
( 0 . 047-0 . 068 )  
0 . 081 0 . 540 + 37 . 4  
( 0. 049-0 . 11 3) 
* Represents the group average of  fi ve animals. 
** Calculated on the micromoles of formaldehyde 
p roduced per gram of 1 i ver tissue . 
ori gi na 1 1 O percent 1 i ver ti ssue homogenate was di 1 uted to 1 O ml with 
di sti lled water . These di lutions were then analyzed for protei n con­
tent . The results of the experi ment are shown on Table 2, where each 
fi gure represents the average l i ver protei n concentrat i on o f  five 
ani mals . Data are expressed as mi lli grams of protei n present per 1 00 
mi lli grams of  l i ver t i ssue . The results of thi s study i ndicate that 
9 mg/k g  of  phenobarbi tal decreased li ver protei n concen trati on, that 
90 mg/kg of  tri methadi one had li ttle .or no effect on l i ver protein 
concentrat i on, and that 30 mg/kg of di phenylhydan toi n  and -54  mg/kg 
of ethosuxi mi de i ncrease li ver protei n concentrati on by 34 . 6  percent 
and 33.0 percent respecti vely . 
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The i nfluence of phenobarbi tal ,  diphe.!'_Y-lhydantoi n ,  tri irethadi one 
and ethosuxi mide on bo<!Y_ wei_ght and li ver wei qh� of y_oung adult female 
rat�. To detenni ne the effect of phenobarbi tal, di phenylh>'danto i n, 
trirrethadi one, and ethosuxi mi de on total body wei ght of  young adult 
female rats, each ani mal was weighed pri or to drug admi n i strati on and 
just before sacri fi ce. To determine the effect of these agents on 
li ver wei ght, li vers . were exci sed , ri nsed in rhosphate buffer ( pH 
7 . 4),  pat dri ed and wei ghed . The results of the experiment are shown 
on Table 3, where each fi gure represents the average value ob�ained 
from groups of fi ve ani mals . Unless otherwi se stated, data are expressed 
i n  grams of ti ssue . The results of thi s  study i ndi cate that the admi n­
i strati on of 30 mg/kg of di phenylhydantoi n caused a decrease i n  body 
wei ght ; whereas 9 mg/kg of phenobarbi tal, 90 mg/kg of tri methadi one 
and 54 mg/kg of  ethosuxi mi de caused a sli ght wei gh t  i ncrease . Results 
TABLE 2 
THE INFLUENCE OF PHE NOBARBITAL , OIPHE NYLHYDAN-TOIN , TRIMETHADIONE  
AND ETH OSUXIMIDE ON THE CONTENT OF  PROTEIN IN  TH E LIVER OF YOUNG 
ADULT FEMAL E  RATS 
GROUP LIVER TISSUE PERCENT 
PROTEIN* VARIATION 
( Mg per 1 00 mg 
1 i ve r ti s sue ) 
Control 34 . 30 
( 32 . 00 - 38 . 00 )  
Phenobarbital 27 . 25 -20 . 3 
( 22 . 50 - 30 . 00 )  
Di phenylhydantoin 46 . 05 +·34 . 6  
( 33 . 1 0 - 52 . 00 )  
Trimethadione 33 . 95 - o .  7 
( 3 1 . 00- 36 . 00 )  
Ethosuxi mi de 45 . 50 +33 . 0  
( 38 . 50 -52 . 50 )  
* Represents the group average of five animals. 
1 7  
TABLE 3 
THE INFLUENCE OF PHENOBARBI TAL , DI PHENYLHYDANTO I N ,  TRIMETHADI ONE 
AND ETHOSUX I M I DE ON BODY WEI GHT AN D LIVER WEIGHT OF  YOUNG 
ADULT FEMALE RATS 
GROUP BEGI NN I NG END  NET  LI VER MG OF t IVER 
WEIGHT* WEIGHT* CHAN GE* WEIGHT* PER GM OF 
1 8  
( GM)  ( GM )  ( GM )  { GM)  BODY WE IGHT* 
Control 205 . 2  218 . 0  +1 2 . 8 6 . 86 4  31 . 49 
Phenobarb i tal 1 9 7 . 6  207 . 8  + 1 0 . 2  6 . 9 57  33 . 48 
Diphenylhydantoin 209 . 6  1 85 .6  -24 . 0  5 . 081  2 7 . 38 
Tri methadi one 1 80 . 2  208 . 6  +28 . 4  6 . 923 33 . 19 
Ethosuxi mi de 1 76 . 8  21 4 .0 +37 . 2  7 . 129 33 . 31 
* Represents the group average of five animals . 
also indicate that the administration of 30 mg/kg of diphenylhydan·­
toin caused a su�stanti al decrease in the wei gh t of the liver and 
that the injection of 9 mg/kg of phenobarbital, 30 mg/kg of tri­
rrethadione and 54 mg/kg of ethosuximide caused a sligh t increase in 
the weight. of this group. 
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D I SCUSS ION 
The purpose o f  this study was to obtain infonnation concerning 
the effects of phenobarbital, diphenylhydantoin , trimethadione and 
ethosuximide on microsomal den�thylase activity and liver tissue 
protein. In additi on, the effects of these compounds on total body 
weight and 1 i ver weight were noted. 
Barbi turates and hydantoins are used primarily for grand mal 
epilepsy ; oxazolidi nes and succinimides are used primarily for the 
peti t mal types (12). Members of  more than one drug fami ly may be 
· used concurrently to control the epileptic patient, or one family 
may be substituted for another for the sarre purpose (1 O )  • It has 
20 
not been established whether the denethylase enzyme system being 
investigated is specific for rrethyl groups or if it will dealkylate 
larger groups (7 ) .  The coll'l)ounds employed in this study all contain 
alkyl groups i n  their chemical configuration. The influence o f  these 
agents on derrethyl ase activity could be of value in situations where 
the physician is interchanging rredications or attempting to arrive 
at a proper dosage regimen. Several investigators have noted that 
diphenylhydantoin levels are lowered in animals pre-treated and treated 
concurrently with phenobarbital (11, 18). 
In this study phenobarbital stimulated derrethy lase activity which 
concurs with previously published work (1-4). Although so� investi­
gators report greater degrees of induction (1 ,2) ,  the dosages 
administe red in their studies were considerably hi.gher than those used 
in our experirrents. A lower dosage was employed to roore nearly 
approach that whi ch mi ght be admi ni stered i n  a cli ni cal s i tuati on .  
The dosages used were acqui red by tak i ng the usual adul t  da i ly  dose  
of the drug i n  questi on and nul tip lyi ng it by five ( 13 ) . Thi s 
quantity was d i vi ded by 70 ( 70 kil ograms is cons i dered the average 
adul t wei ght) to obtai n an averag e dose on a mil ligram per kil ogram 
body wei ght bas i s . In our i ni ti al experi ment, 9 mg /kg of pheno­
barbi tal , a cofTl)ound general l y  considered to be the prototype of 
compounds which cause sti mu l ati on of vari ous micros omal enzyrres 
incl udi ng denethyl a se, caused approximately a two- fol d i ncrease i n  
derrethylase acti vi ty ;  therefore, it was decided that thi s method o f  
determi ni ng dosage and the research procedure were satisfactory for 
eval uation of other anti -epil epti c agents. 
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Sone di sagreenent exis ts in the l iterature concerning the effects 
of di pheny lhydantoi n on mi crosomal demethy l ase systems. E l ing et �-
( 8) admi nistered 100 mg/k g  of di phenyl hydantoi n i ntraperi tonea 11 y and 
demonstrated an increase in demethylase activi ty ;  Pl att an d Cockri l l  
( 9 )  administered 200 mg/kg of di phenyl hydantoin oral ly  and found that 
this dosage di d not · effect the derrethylase activity . In thi s study 
the i.ntraperitoneal admini stration of 30 mg/kg of dipheny l hydantoi n 
caused a s l i ght decrease  i n  derrethyl ase acti vity . 
From the data acqui red i n  this study , it was concl uded that 
tri nethadi one caused no effect on demethy l ase activity . Thi s con­
cl us ion paral l el s  the findings of Conney ( 1 8) .  
The admi ni strati on of  54 mg/kg of ethosuximide caused an appreciabl e  
increase i n  deroothyl ase acti vi ty i n  the l iver o f  the fema l e rat. This 
appears to be the first indication concerning the .effects of 
succinimide compounds on microsomal enzyme systems. 
Orreni us et tl• ( 2 ) state that microsomal protein of the 1 i ver 
can be increased by prolonged treatment with phenobarbital. Arias 
et !]_. ( 3) report that phenobarbital does not alter protein degrada­
tion rates but rather increases protein synthesis in smooth endo­
plasmic reticulum. The results of this study indicate that 9 mg/kg 
of phenobarbital caused a decrease in the liver protein concentration 
and that 90 mg/kg o f  trinl'!thadione caused no effect on the liver 
_protein concentration. 
The significance of the increased protein content of the group 
recei vi ng 30 mg/kg diphenylhydantoin is clouded by the unusually small 
livers found in this group . Liver protein appea .red to be increased 
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by injections of 54 mg/kg of ethosuximide . Arias et tl• (3) state that 
the half life of liver proteins is 2 to 2. 5 days and a rapid turnover is 
continually taking place . Thus drug induced variations in l i ver 
protein would be possi ble with the 5-day treatrrent period. 
Conney et .!1_. ( 1) deroonstrated both an increase  in activi ty and 
an increase in actual liver size following phenobarbital admi nistra­
tion. In our experiments the livers of rats treated with phenobar­
bital, trimethadione and ethosuximide were slightly larger than those 
of the control . Li vers from di phenyl hydantoi n treated animals were 
sonewhat smaller ·than the control as al so was the body weight smaller 
than the control . Lesser values than control values occurred onl y in 
the latter group . The significance of these data i s  not understood. 
Gilbert and Golberg state there is no correlation between liver size 
and the enzyrre activity it may have (19) . It has been reported that 
about one-third of the humans given large doses of diphenylhydantoin 
experience hyperlasia of the gums (20) . If this manifestation should 
occur in rats , an e xp l anation might then be available for the weig ht 
loss experienced by this group . Nothing was found in the literature 
discussi ng this reaction in rats . Literature on trirrethadione (2 1 )  
and ethos uxi mi de (22) �nti on the possibility of drowsiness occurring 
while on these rredications . Although the animals exhibited no 
_ outward signs of  drowsiness , the occurrence is occasional and may 
influence body weight . In this study we did not monitor food and 
water cons ump ti on ,  or conti nuously observe the activity of . the test 
animal s .  In order to mo re  completely evaluate the effects of  these 
compounds on microsomal enzyfle activity, it would be necessary to 
obtain this information . 
Observations during drug admi ni strati on revealed the rats 
receiving diphenylhydantoin became groggy and lethargic post-
; nject ion . These e ffects were evident approximately 5 minutes after 
injections were made and persisted up to 1 20 minutes . . The rats 
seemed rrentally alert when handled yet when allowed to remain quiet , 
they preferred to lay down and remained listless throughout this 
period. The irritating effect of diphyl hydantoin on the peritoneal 
cavity might exp_l ai n thi s  response ( 8) . 
2 3  
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SUMMARY 
1 .  The modified procedure of La Du ( 1 3 ,1 4) was used to evaluate 
the microsomal enzyme system of the rat live r that demethylates amino­
pyri ne. 
2. The protein content of the 1 i ver tissue was rreas ured by use 
of the standard Biuret test . 
3 .  Daily intraperitoneal injections of 9 mg/kg of sodium pheno­
barbital to youn g adult female rats for five days caused approximately 
a two-fol d increase in the derrethylase activity of liver microsomes. 
· rhe percentage of liver protein was decreased approximately 20 percent . 
4 .  Daily intraperitoneal injections of 90 mg/kg of diphenyl­
hydantoin to young adult female rats for five days caused a slight 
decrease in derrethylase activity in the liver microsorres. Liver protei n 
was considerably elevated following drug administration . 
5. Daily intraperitoneal injections of 30 mg/kg of trimetha­
dione to young adult female rats for five days caused no variation in 
the dermthylase activity in liver microsorres. The Biuret test showed 
that this treatrrent did not effect the protein concentration of  the 
1 i ver. 
6 . Daily · intraperitoneal injections of 54 mg/kg of ethosuximide 
to young adult female rats for five days caused an appreciab le i ncrease 
in the denethylase activity of the liver microsomes. Protein analysis 
indicated that this treatrrent caused approximately 33 perce nt increase 
in protein content of the liver. 
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